“…[1] Currently, MNRs DOI: 10.1002/adma.202306876 powered by various mechanisms, such as chemical, [2][3][4][5] light, [6][7][8][9] magnetic, [10][11][12][13] ultrasound, [14][15][16] and more advanced hybrid mechanisms, [17][18][19][20][21][22] have been extensively studied and display diverse types of motion. In this regard, MNRs outperform traditional passive nanocarriers in terms of targeting capability, [23][24][25] drug delivery efficiency, [26][27][28] and tissue penetration [29][30][31] based on their active movement. Although targeting movement of MNRs to several organs and large cavities (e.g., brain, [3,17,32] gastrointestinal tract, [33][34][35] and bladder [36,37] ) has been achieved, considering the velocity limited by their tiny bodies, human-scale navigation of MNRs will inevitably result in a compromise of the delivery efficiency.…”